Case Studies / Visual abstract series for ASCO and ESMO: 18 abstracts …
Medical Affairs Evidence Generation Omnichannel Content Oncology

Visual abstract series for ASCO and ESMO oncology congresses: 18 abstracts transformed into shareable medical infographics

Challenge
Text-heavy congress summaries were not being read. MSL teams needed visually immediate formats they could use in field conversations and share with KOLs.
Approach
Designed a systematic visual abstract production pipeline — scientific accuracy review, visual hierarchy design, and audience-specific formatting — for 18 priority abstracts across two major congresses.
Result
Visual abstracts achieved significantly higher engagement than equivalent text-only summaries on internal medical channels.
The challenge

The data was strong. Nobody was reading it.

Following back-to-back ASCO and ESMO congress cycles, the Medical Communications team had produced 18 high-quality text summaries covering the most strategically relevant abstracts. The scientific accuracy was strong. The summaries were thorough and internally approved. And they were not being read.

An internal audit found that MSLs were opening only a fraction of the summaries sent. Of those opened, reading time was insufficient to absorb the clinical content. KOLs were not circulating the documents. The information existed; the format was failing.

Scientific accuracy is a necessary condition for medical communications materials. It is not a sufficient one. If the format does not work for the audience, the science goes unread.

Our approach

What we did

1
Abstract prioritisation
With the Medical Affairs team, selected the 18 abstracts with the highest strategic value — those most relevant to the brand's current evidence narrative, competitive landscape, and ongoing reimbursement discussions.
2
Visual abstract framework design
Developed a visual abstract template framework with a consistent structure: study design summary, primary endpoint visualisation, key secondary data, and clear bottom-line takeaway. Designed for immediate scanning in under 60 seconds.
3
Scientific accuracy review
Each visual abstract underwent two rounds of medical review: one for scientific accuracy against the source abstract, one for messaging alignment with the brand's approved evidence narrative. Any ambiguity in data visualisation was resolved conservatively.
4
Format variants
Produced each visual abstract in three formats: print-ready PDF for formal meetings, digital-optimised version for email and portal distribution, and a cropped single-panel version for slide deck integration.
5
Distribution and engagement tracking
Deployed through the internal medical portal with engagement tracking. Measured open rates, time spent, and forward/share actions against baseline text-only summaries for the same abstracts.
Result

Measurable impact

The 18 visual abstracts achieved significantly higher open rates and longer engagement times compared to equivalent text summaries. Three of the visual abstracts were circulated by KOLs to their own networks, generating secondary reach. The internal Medical Communications team adopted the visual abstract format as the standard output for all major congress coverage, replacing the text summary as the primary field communication format.

Significantly higher
engagement
vs text-only summaries — open rate and time spent
18
Visual abstracts produced across ASCO and ESMO cycles
3
KOL-circulated abstracts generating secondary network reach
Facing a similar challenge?

Tell us what you’re working on — we’ll show you relevant cases and suggest the fastest path forward.

Evidence Scanner
Evidence ScannerTM
AI infrastructure

AI-powered.
Expert-validated.

We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.

Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Electronic data capture with AI-assisted structuring of unstructured records
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
Evidence Scanner · Research module
// Query: ribociclib OS data MONALEESA 2023–24
search("ribociclib overall survival", {
  years: [2023, 2024],
  output: "structured_table"
})
// 847 records → 23 relevant
Processing 847 records...
Evidence Summary
MONALEESA-2 updated OS (NEJM 2023): median OS 63.9 mo vs 51.4 mo (HR 0.76, 95% CI 0.63–0.93). Benefit maintained across all pre-specified subgroups...